| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/05/2001 | WO2001012592A3 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 07/05/2001 | WO2001002005A3 Treatment of dentritic cells for induction of immune tolerance |
| 07/05/2001 | WO2001000824A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 07/05/2001 | WO2000078332A3 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/05/2001 | WO2000074714A3 Indicators for monitoring the technique of transcutaneous immunization |
| 07/05/2001 | WO2000073278A3 5-phenyl-pyrimidine derivatives |
| 07/05/2001 | WO2000071679A3 Human oxidoreductase proteins |
| 07/05/2001 | WO2000070046A3 Secreted polypeptides and corresponding polynucleotides |
| 07/05/2001 | WO2000069896A3 Molecular interactions in haematopoietic cells |
| 07/05/2001 | WO2000068195A3 Substituted pyrrolidines as cell adhesion inhibitors |
| 07/05/2001 | WO2000061621A3 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/05/2001 | WO2000023114A9 Polymer conjugates of interferon beta- 1a and their uses |
| 07/05/2001 | US20010007017 For preventing AIDS or slowing down its progression |
| 07/05/2001 | US20010006973 1-oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels |
| 07/05/2001 | US20010006947 Methods of administering adenoviral vectors |
| 07/05/2001 | US20010006942 Inducing an immune response against a chemokine receptor molecule by administering an immunogenic chemokine receptor polypeptide from an extracellular region of a chemokine receptor molecule; treating inflammation, multiple sclerosis |
| 07/05/2001 | US20010006798 Novel FtsL |
| 07/05/2001 | US20010006792 Immunomodulatory properties |
| 07/05/2001 | US20010006681 Chemokine inhibition of immunodeficiency virus |
| 07/05/2001 | US20010006642 Delivering antigens or biologically active polypeptides to a subject in need of same by administering to the subject a non-invasive or non-pathogenic bacterium which expresses the antigens or polypeptides |
| 07/05/2001 | US20010006641 Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80 |
| 07/05/2001 | US20010006640 Compounds and methods to inhibit or augment an inflammatory response |
| 07/05/2001 | DE19963178A1 Substituierte Indol-Mannichbasen Substituted indole Mannich bases |
| 07/05/2001 | DE19960443A1 Verfahren zur Auffindung von Nukleotidsyntheseinhibitoren mit weniger Nebenwirkungen A method for finding nucleotide synthesis inhibitors with fewer side effects |
| 07/05/2001 | CA2699568A1 Azaindoles |
| 07/05/2001 | CA2396693A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | CA2396579A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | CA2396502A1 Substituted pyrrole mannich bases |
| 07/05/2001 | CA2395834A1 Tricyclic compounds |
| 07/05/2001 | CA2395663A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395544A1 Method of achieving persistent transgene expression |
| 07/05/2001 | CA2395543A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395524A1 Chemotherapeutant screening method |
| 07/05/2001 | CA2395284A1 Inhibition of gsk-3.beta. |
| 07/05/2001 | CA2395276A1 Identification of novel splice variants of the human catalytic subunit c.beta. of camp-dependent protein kinase and the use thereof |
| 07/05/2001 | CA2395242A1 Composition for inhibiting macrophage activity |
| 07/05/2001 | CA2395236A1 Basolateral sorting signal and inhibitors thereof |
| 07/05/2001 | CA2395179A1 Nitrile derivatives as cathepsin k inhibitors |
| 07/05/2001 | CA2395173A1 Pyrrolidines which inhibit camp-specific pde |
| 07/05/2001 | CA2394880A1 Activation and inhibition of the immune system |
| 07/05/2001 | CA2394748A1 Optimized minigenes and peptides encoded thereby |
| 07/05/2001 | CA2394727A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | CA2394393A1 Remedies for external use for allergic skin diseases |
| 07/05/2001 | CA2394295A1 Antibodies against plasma cells |
| 07/05/2001 | CA2394174A1 A molecular switch for regulating mammalian gene expression |
| 07/05/2001 | CA2394098A1 Substituted 1 and 2 naphthol mannich bases |
| 07/05/2001 | CA2393583A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | CA2393529A1 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | CA2392866A1 Substituted indole mannich bases |
| 07/04/2001 | EP1112365A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same |
| 07/04/2001 | EP1112362A2 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 07/04/2001 | EP1112358A2 Dna sequence encoding oncofetal ferritin protein |
| 07/04/2001 | EP1112286A1 Secreted proteins and polynucleotides encoding them |
| 07/04/2001 | EP1112262A1 SUBSTITUTED $g(g)-PHENYL-$g(D)-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO |
| 07/04/2001 | EP1112255A1 4,4-biarylpiperidine derivatives with opioid receptor activity |
| 07/04/2001 | EP1112251A1 Azetidine derivatives, preparation and medicines containing them |
| 07/04/2001 | EP1112083A2 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 07/04/2001 | EP1112072A2 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases |
| 07/04/2001 | EP1112070A1 Novel substituted triazole compounds |
| 07/04/2001 | EP0850236B1 Piperazino derivatives as neurokinin antagonists |
| 07/04/2001 | EP0814776B1 Topically applied pharmaceutical composition, method of preparing it and its use |
| 07/04/2001 | EP0634927B1 Treatment and prophylaxis of diseases caused by parasites, or bacteria |
| 07/04/2001 | CN1302296A Novel 2-alkyl substituted imidazole compounds |
| 07/04/2001 | CN1302209A Polyol-IFN-beta conjugates |
| 07/04/2001 | CN1301848A New polypeptide-NADH dehydrogenase subunit I-11 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301771A New polypeptide-human gonadotrophin-releasing hormone 11 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301767A New polypeptide-human RS3 protein 13 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301766A New polypeptide-human protein hydrolase regulating protein 9 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301761A New human chemotaxis factor macrophage inflammatory protein, its coding sequence and use |
| 07/04/2001 | CN1301756A New polypeptide-myelin PO protein 14 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301745A New polypeptide-amyloid glucoprotein 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301743A New polypeptide-cytochrome b 12 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301732A New polypeptide-thiolase protein 11 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301722A New polypeptide-heparin binding protein 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301717A New polypeptide-gitter protein light chain 12 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301713A New polypeptide-stathmin-protein 8 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301709A New polypeptide-small hydrophilic vegetable seed protein 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301573A High energy health water |
| 07/04/2001 | CN1301564A Cordyceps medicinal composition and its preparing method |
| 07/04/2001 | CN1301563A Medicine for curing rheumatoid arthritis and preparing method |
| 07/04/2001 | CN1067986C 1H-indole-3-acetic acid hydrazide phospholipid enzyme A2 inhibitors |
| 07/03/2001 | US6255458 High affinity human antibodies and human antibodies against digoxin |
| 07/03/2001 | US6255456 Enzymatic polypeptide; for use in diagnosis, detection, prevention and treatment of cancer and immune defects |
| 07/03/2001 | US6255453 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 07/03/2001 | US6255348 Use of aminoadamantane compounds as immunoregulators |
| 07/03/2001 | US6255341 Nutrients; mixture of vitamins, triglycerides and protein |
| 07/03/2001 | US6255294 Absorption by mucous membrane |
| 07/03/2001 | US6255283 Use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (TNF) |
| 07/03/2001 | US6255281 Complexing uteroglobin to fibronectin |
| 07/03/2001 | US6255107 An antibody reacting with a cell surface antigen expressed on tryptase and chymase positive human mast cells; treatment of allergic disease, bronchial asthma, allergic rhinitis |
| 07/03/2001 | US6255100 Cyclosporin fermentation process |
| 07/03/2001 | US6254885 Containing: cyclosporin, ethanol or propylene glycol, non-ionic polyoxyalkylene surfactant, cosolvent; high bioavailability, used in immuno-suppressive therapy |
| 07/03/2001 | US6254874 Attenuated auxotrophic microorganisms having a combination of non-attenuating mutations and method for making same |
| 07/03/2001 | CA2116348C Sirs vaccine and diagnosis method |
| 06/30/2001 | CA2293852A1 Procedure for preparing active plant extracts used to trap free radicals; the extracts and compounds and devices containing them |
| 06/28/2001 | WO2001046698A2 Tethered ligands and methods of use |
| 06/28/2001 | WO2001046443A2 Proteases |
| 06/28/2001 | WO2001046397A2 Human kinases |
| 06/28/2001 | WO2001046394A2 Mammalian protein phosphatases |
| 06/28/2001 | WO2001046392A2 Homologues of human heparanase and splice variants thereof |